These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31375467)

  • 1. Antimalarial drug resistance in Africa: the calm before the storm?
    Conrad MD; Rosenthal PJ
    Lancet Infect Dis; 2019 Oct; 19(10):e338-e351. PubMed ID: 31375467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination.
    Ouji M; Augereau JM; Paloque L; Benoit-Vical F
    Parasite; 2018; 25():24. PubMed ID: 29676250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
    Blasco B; Leroy D; Fidock DA
    Nat Med; 2017 Aug; 23(8):917-928. PubMed ID: 28777791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for new antimalarial drugs less prone to resistance.
    Noedl H
    Curr Pharm Des; 2013; 19(2):266-9. PubMed ID: 22973887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Calculating and Reporting Antimalarial Efficacy against Plasmodium falciparum in Sub-Saharan Africa: A Systematic Review of Published Reports.
    Plucinski MM; Hastings IM; Moriarty LF; Venkatesan M; Felger I; Halsey ES
    Am J Trop Med Hyg; 2021 Mar; 104(5):1820-1829. PubMed ID: 33724925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance.
    von Seidlein L; Dondorp A
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):715-30. PubMed ID: 25831482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
    Sutherland CJ; Babiker H; Mackinnon MJ; Ranford-Cartwright L; El Sayed BB
    Parasitology; 2011 Oct; 138(12):1459-68. PubMed ID: 21810298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin Resistance Outside of Southeast Asia.
    Rosenthal PJ
    Am J Trop Med Hyg; 2018 Dec; 99(6):1357-1359. PubMed ID: 30426924
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs): Fears of widespread drug resistance].
    Benoit-Vical F; Paloque L; Augereau JM
    Bull Acad Natl Med; 2016 Mar; 200(3):477-89; discussion 490. PubMed ID: 28644374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
    van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
    Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.
    Ménard S; Ben Haddou T; Ramadani AP; Ariey F; Iriart X; Beghain J; Bouchier C; Witkowski B; Berry A; Mercereau-Puijalon O; Benoit-Vical F
    Emerg Infect Dis; 2015 Oct; 21(10):1733-41. PubMed ID: 26401601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
    Zhou LJ; Xia J; Wei HX; Liu XJ; Peng HJ
    Parasitol Res; 2017 Feb; 116(2):781-788. PubMed ID: 28028628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Artemisinin-Based Combination Therapies For Malaria Beginning To Fail in Africa?
    Rosenthal PJ
    Am J Trop Med Hyg; 2021 Sep; 105(4):857-858. PubMed ID: 34491214
    [No Abstract]   [Full Text] [Related]  

  • 18. No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
    Vincent JP; Komaki-Yasuda K; Existe AV; Boncy J; Kano S
    Emerg Infect Dis; 2018 Nov; 24(11):2124-2126. PubMed ID: 30334724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of artemisinin partial resistance in Africa: how do we respond?
    Rosenthal PJ; Asua V; Bailey JA; Conrad MD; Ishengoma DS; Kamya MR; Rasmussen C; Tadesse FG; Uwimana A; Fidock DA
    Lancet Infect Dis; 2024 Sep; 24(9):e591-e600. PubMed ID: 38552654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
    Talisuna AO; Karema C; Ogutu B; Juma E; Logedi J; Nyandigisi A; Mulenga M; Mbacham WF; Roper C; Guerin PJ; D'Alessandro U; Snow RW
    Lancet Infect Dis; 2012 Nov; 12(11):888-96. PubMed ID: 23099083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.